| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7514448 | International Journal of Drug Policy | 2012 | 5 Pages |
Abstract
The HCV-seroconversion rate was 10 times higher among new-injectors than never-injectors. No predictors other than starting injecting were found for HCV-seroconversion. Harm reduction interventions to prevent HCV infection should include prevention of drug injection.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
MarÃa J. Bravo, Fernando Vallejo, Gregorio Barrio, M. Teresa Brugal, Gemma Molist, José Pulido, Luis Sordo, Luis de la Fuente, the ITINERE Project Group the ITINERE Project Group,